HST Global, Inc.
HSTCOTCHealthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$140,907 | −$141,035 | −$145,718 | −$207,978 | −$151,554 | −$142,587 |
| Net income | −$146,210 | −$145,074 | −$148,360 | −$208,992 | $426,572 | −$178,335 |
| Total assets | $1,526 | $190 | $225 | $660 | $1,955 | $0 |
| Total liabilities | $593,593 | $446,047 | $301,008 | $153,083 | $5,385 | $3.4M |
| Equity | −$592,067 | −$445,857 | −$300,783 | −$152,423 | −$3,430 | −$3.4M |
| EPS (diluted) | $-0.03 | $-0.03 | $-0.03 | — | — | — |
| Shares out. | 5.2M | 5.2M | 5.2M | 4.2M | 4.2M | 36.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- —
- Net margin
- —
- Return on equity
- 24.7%
- Return on assets
- −9581.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 38898.6%
- Debt / equity
- —
- Book value / share
- $-0.11
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -16015.65distress
- Accruals / assets
- −8211.3%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 2 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 2, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Field Michael LActivist (13D)Nov 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Mar 31, 2025 | 96 | 1.0 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity saleMar 20, 2025
- Entered a material agreement · Unregistered equity saleNov 12, 2024
- Entered a material agreement · Unregistered equity saleSep 26, 2024
- Entered a material agreement · Unregistered equity sale · Change in control · Director / officer change · Amended charter or bylaws · Other material eventMay 3, 2024
- Changed auditorApr 28, 2020
- Entered a material agreementAug 22, 2019
- Changed auditor · Other material eventApr 8, 2013
- Director / officer changeMay 13, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13DNov 10, 2025
- 15-12GNov 3, 2025
- 10-KNov 3, 2025
- NT 10-KNOTIFICATION OF LATE FILINGApr 2, 2025
- NT 10-KFORM NT 10-KMar 31, 2025
- 8-KCURRENT REPORT ON FORM 8-KMar 20, 2025
- 10-QHST GLOBAL, INC. - FORM 10-Q SEC FILINGNov 22, 2024
- NT 10-QNov 15, 2024
- 8-KFORM 8-KNov 12, 2024
- 8-KCURRENT REPORT ON FORM 8-KSep 26, 2024
- 10-QHST GLOBAL, INC. - FORM 10-Q SEC FILINGAug 26, 2024
- NT 10-QNOTICE OF INABILITY TO TIMELY FILE FORM 10-QAug 16, 2024
- 10-QHST GLOBAL, INC. - FORM 10-Q SEC FILINGJun 5, 2024
- 3PRIMARY DOCUMENTMay 16, 2024
- 3PRIMARY DOCUMENTMay 16, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.